Page 1 | Search Results | Blood | American Society of Hematology

1-12 of 12

Sort by

Sort Order Select

Journal Articles

Molecular Screening of 28 Genes in Mexican Patients with Acute Myeloid Leukemia a Series of 70 Patients from the Instituto Nacional De Cancerologia, Mexico

Nidia Zapata, MD, Espinoza Ramiro, III, Eduardo Cervera, Judith Cruz, MD, Diana Arcos, MD, Juan Labardini, MD

Blood (2018) 132 (Supplement 1): 5197.

https://doi.org/10.1182/blood-2018-99-115300

Published: 2018

Journal Articles

Azacitidine Use in a Low Income Country, Effectiveness of a 100mg Fixed Dose

Jorge Carlos Torres, Sr., Resident, Nidia Zapata, MD, Eduardo Cervera, Sergio Sanchez, Manuel Aguilar, Resident

Blood (2016) 128 (22): 5555.

https://doi.org/10.1182/blood.V128.22.5555.5555

Published: 2016

Journal Articles

Phase II Study of Epigenetic Therapy with Hydralazine and Valproate in Cutaneous T-Cell Lymphoma

Ramiro Espinoza, MD, Manuel Aguilar Rodríguez, MD, Nidia P. Zapata, MD, Jorge Carlos Torres, Sr., Resident, Diana Berenice Nolasco, MD, Silvia Eugenia Alarcon Barrios, Eduardo Cervera, Myrna Candelaria, MD PhD, Valentin Lozano, Alejandro Sosa, Javier Espinoza, Magnolia Vieyra, Jorge Gutierrez, Luis Mario Sosa, Reynaldo González, Luis Oñate, Juan Labardini

Blood (2016) 128 (22): 5362.

https://doi.org/10.1182/blood.V128.22.5362.5362

Published: 2016

Journal Articles

Functional and Pain Score Improvement with Vertebroplasty in De Novo Multiple Myeloma in a Public Institution in Mexico

Jorge Carlos Torres, Sr., Resident, Ramiro Espinoza, MD, Silvia Alarcon, Nidia Zapata, MD, Eduardo Cervera, Alejandro Sosa, Magnolia Vieyra, MD, Javier Espinoza, Luis Sosa, MD, Luis Oñate, Juan José Lahuerta, MD PhD, Manuel Aguilar, Resident

Blood (2016) 128 (22): 3324.

https://doi.org/10.1182/blood.V128.22.3324.3324

Published: 2016

Journal Articles

Local Experience with Autologous Stem Cell Transplant in Multiple Myeloma at a Public Institution (Instituto Nacional de Cancerologia)

Eduardo Cervera, Jorge Carlos Torres, Sr., Nidia P. Zapata, MD, Juan Rafael Labardini, Sr., Hematologist, Jose Ramiro Espinoza, Hematologist, Magnolia Vieyra, MD, Antonio Sosa, Valentin Lozano, MD, Myrna Candelaria, MD PhD, Abelardo Meneses, MD

Blood (2015) 126 (23): 5504.

https://doi.org/10.1182/blood.V126.23.5504.5504

Published: 2015

Journal Articles

Infectious Complications in Acute Leukemia, Experience in a Public Institution in Mexico

Nidia P. Zapata, MD, Jorge Carlos Torres, Sr., Ramiro Espinoza, Eduardo Cervera

Blood (2015) 126 (23): 4902.

https://doi.org/10.1182/blood.V126.23.4902.4902

Published: 2015

Journal Articles

Imatinib (IM) Plus Thalidomide (Thali), A Effective Combination For The Treatment Of Chronic Myeloid Leukemia (CML) Philadelphia ChromosomePositive (Ph +) In IM-Resistant Disease. Report Of 14 New Cases From A Single Center In Mexico

Rafael Hurtado Monroy, MD, Pablo Vargas-Viveros, MD, Eduardo Cervera Ceballos, MD, Judith Cruz Velazquez, Silvia Carrillo Munos, RN

Blood (2013) 122 (21): 5172.

https://doi.org/10.1182/blood.V122.21.5172.5172

Published: 2013

Journal Articles

Chronic Myeloid Leukemia Philadelphia Chromosome Positive (CML Ph+) with Imatinib (IM) Intolerance or Resistant Disease. Response to Thalidomide (TALI) Treatment. Preliminary Report of a Serial of Cases with Encouraging Results

Rafael Hurtado, MD, Jose Pablo Vargas Viveros, MD, Carrillo Muñoz Silvia, RN, Judith Cruz-Velazquez, Myrna Candelaria, MD, PhD, Eduardo Cervera, MD

Blood (2012) 120 (21): 1689.

https://doi.org/10.1182/blood.V120.21.1689.1689

Published: 2012

Journal Articles

Bcr-Abl Mutations in Chronic Myeloid Leukemia - Impact on Survival and Treatment with Second Generation Inhibitors– A Study on Behalf of Latin American Leukemia Net (Lalnet)

Blood (2011) 118 (21): 1701.

https://doi.org/10.1182/blood.V118.21.1701.1701

Published: 2011

Journal Articles

The Age of Mexican Patients with Chronic Myeloid Leukemia (CML) Ph+ Is Quite Younger Than the Reported in USA and European Series.

Pablo Vargas-Viveros, M.D., Rafael Hurtado Monroy, MD, Eduardo Cervera, MD, Carlos Best, M.D., Alvaro Aguayo, M.D., Myrna Candelaria, MD

Blood (2009) 114 (22): 4291.

https://doi.org/10.1182/blood.V114.22.4291.4291

Published: 2009

Journal Articles

Plasma Circulating Levels of Soluble P-Selectin and Thrombospondin-1 (TSP1) Are Elevated in Patients with Cancer and a Shortened Activated Partial Thromboplastin Time (APTT) without Clinical Evidence of Thrombosis: An Inexpensive and Simple Test (APTT) To Be Considered for Its Clinical Value.

Fabiola E. Del Carpio-Cano, PhD, Diana Zamora-Rangel, Ph.D., Miguel A. Rosales-Manoatl, Ph.D., Maria R. Rivas-Gonzalez, MD, Eduardo Cervera-Ceballos, MD, Raul A. De La Cadena, MD

Blood (2006) 108 (11): 4098.

https://doi.org/10.1182/blood.V108.11.4098.4098

Published: 2006

Journal Articles

Imatinib Alone (IA) Vs. Imatinib + Ara-C (IMAC): A Randomized Phase III Clinical Trial for the Treatment of Early Phase (EP) Chronic Myeloid Leukemia (CML) Ph+. Preliminary Report of Mexican Cooperative Leukemia Group (GRUMELA).

Rafael Hurtado Monroy, MD, Pablo Vargas-Viveros, MD, Eduardo Cervera, MD, Myrna Candelaria, MD, Alvaro Aguayo, MD, Emma Gallardo, MD, Eucario Leon, MD, Juan Labardini, MD, Ricardo Sosa, MD, Rogelio Paredes, MD, Fernando Romero, MD, Oscar Perez, MD, Omar Coronel-Ayala, MD

Blood (2004) 104 (11): 1015.

https://doi.org/10.1182/blood.V104.11.1015.1015

Published: 2004

NARROW

Molecular Screening of 28 Genes in Mexican Patients with Acute Myeloid Leukemia a Series of 70 Patients from the Instituto Nacional De Cancerologia, Mexico

Azacitidine Use in a Low Income Country, Effectiveness of a 100mg Fixed Dose

Phase II Study of Epigenetic Therapy with Hydralazine and Valproate in Cutaneous T-Cell Lymphoma

Functional and Pain Score Improvement with Vertebroplasty in De Novo Multiple Myeloma in a Public Institution in Mexico

Local Experience with Autologous Stem Cell Transplant in Multiple Myeloma at a Public Institution (Instituto Nacional de Cancerologia)

Infectious Complications in Acute Leukemia, Experience in a Public Institution in Mexico

Imatinib (IM) Plus Thalidomide (Thali), A Effective Combination For The Treatment Of Chronic Myeloid Leukemia (CML) Philadelphia ChromosomePositive (Ph +) In IM-Resistant Disease. Report Of 14 New Cases From A Single Center In Mexico

Chronic Myeloid Leukemia Philadelphia Chromosome Positive (CML Ph+) with Imatinib (IM) Intolerance or Resistant Disease. Response to Thalidomide (TALI) Treatment. Preliminary Report of a Serial of Cases with Encouraging Results

Bcr-Abl Mutations in Chronic Myeloid Leukemia - Impact on Survival and Treatment with Second Generation Inhibitors– A Study on Behalf of Latin American Leukemia Net (Lalnet)

The Age of Mexican Patients with Chronic Myeloid Leukemia (CML) Ph+ Is Quite Younger Than the Reported in USA and European Series.

Plasma Circulating Levels of Soluble P-Selectin and Thrombospondin-1 (TSP1) Are Elevated in Patients with Cancer and a Shortened Activated Partial Thromboplastin Time (APTT) without Clinical Evidence of Thrombosis: An Inexpensive and Simple Test (APTT) To Be Considered for Its Clinical Value.

Imatinib Alone (IA) Vs. Imatinib + Ara-C (IMAC): A Randomized Phase III Clinical Trial for the Treatment of Early Phase (EP) Chronic Myeloid Leukemia (CML) Ph+. Preliminary Report of Mexican Cooperative Leukemia Group (GRUMELA).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only